BamSEC and AlphaSense Join Forces
Learn More

Clovis Oncology Inc

Formerly OTC: CLVSQ
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 97 pages Clovis Oncology, Inc. and the Bank of New York Mellon Trust Company, N.A., as Trustee Indenture Dated as of November 17, 2020 4.50% Convertible Senior Notes Due 2024
12/34/56
EX-4.1
from 8-K 97 pages Clovis Oncology, Inc. and the Bank of New York Mellon Trust Company, N.A., as Trustee Indenture Dated as of [ ], 2020 4.50% Convertible Senior Notes Due 2024
12/34/56
EX-4.6
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 94 pages Clovis Oncology, Inc. and the Bank of New York Mellon Trust Company, N.A., as Trustee Indenture Dated as of August 13, 2019 4.50% Convertible Senior Notes Due 2024
12/34/56
EX-4.2
from 8-K 65 pages Clovis Oncology, Inc. and the Bank of New York Mellon Trust Company, N.A., as Trustee First Supplemental Indenture Dated as of April 19, 2018 1.25% Convertible Senior Notes Due 2025
12/34/56
EX-4.1
from 8-K 48 pages Clovis Oncology, Inc. and the Bank of New York Mellon Trust Company, N.A., as Trustee Indenture Dated as of April 19, 2018
12/34/56
EX-4.2
from POSASR 47 pages Clovis Oncology, Inc. and the Bank of New York Mellon Trust Company, N.A., as Trustee Indenture Dated as of [ ], 2018
12/34/56
EX-4.2
from S-3 47 pages Clovis Oncology, Inc. and [ ] , as Trustee Indenture Dated as of Cross Reference Table
12/34/56
EX-4.1
from 8-K 99 pages Clovis Oncology, Inc. and the Bank of New York Mellon Trust Company, N.A., as Trustee Indenture Dated as of September 9, 2014 2.50% Convertible Senior Notes Due 2021
12/34/56
EX-4.1
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-4.1
from S-1/A 2 pages For Value Received Hereby Sell, Assign and Transfer Unto
12/34/56
EX-4.2
from S-1 50 pages Clovis Oncology, Inc. Investor Rights Agreement May 15, 2009
12/34/56